Key result
This review highlights the current understanding of the pathophysiology and management of myocarditis, cardiomyopathy, arrhythmias, and cardiac arrests as complications of COVID-19.
Why the study?
Although COVID-19 primarily presents with respiratory symptoms, reports have noted cardiovascular complications including myocarditis, requiring an updated understanding of its pathophysiology and management.
This review highlights the pathophysiology and management of myocarditis, cardiomyopathy, arrhythmias, and cardiac arrests as complications of COVID-19.
Alerts clinicians to cardiac complications in COVID-19; leaves open mechanistic and management questions for prospective research.
The world is dealing with a global pandemic of severe acute respiratory coronavirus 2 (SARS-CoV-2). Coronavirus disease 2019 (COVID-19), which is the illness caused by SARS-CoV-2, is overwhelming healthcare systems around the world. Although the main clinical manifestations of COVID-19 are respiratory symptoms, several reports have noted myocarditis, cardiomyopathy, arrhythmias and cardiac arrests as COVID-19 complications. Here, the authors highlight the current understanding of the pathophysiology of myocarditis related to COVID-19 and its management.
No takes yet. Share an insight, caveat, or question.
Abdelnabi et al. (2020) conducted a review in COVID-19 myocarditis. This review highlights the current understanding of the pathophysiology and management of myocarditis, cardiomyopathy, arrhythmias, and cardiac arrests as complications of COVID-19.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: